Records containing: Pancreas Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-09-02Prospective Single-center Study About the Use of Ctdna in the Management of Patients With Tumors of the Gastrointestinal Tract
-
CLINICAL_TRIALS study record update · 2025-09-02Pancreatic Parenchymal Injection of N-Butyl-2-Cyanoacrylate for Pancreaticojejunostomy After Pancreaticoduodenectomy: A Novel Technique
-
CLINICAL_TRIALS study record update · 2025-09-02A Phase 1b/2a Study of Gemcitabine and Nab-paclitaxel in Combination With Avutometinib (VS-6766) and Defactinib in Patients With Previously Untreated Metastatic Adenocarcinoma of the Pancreas
-
CLINICAL_TRIALS study record update · 2025-08-29Neoadjuvant Chemotherapy Followed by Surgery Versus Upfront Surgery for Clearly Resectable Pancreatic Head Cancer and Periampullary Cancer: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-08-27A Phase II Trial of Pharmacological Ascorbate, Gemcitabine, and Nab-Paclitaxel for Metastatic Pancreatic Cancer (PACMAN 2.1)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-08-15First-in-Human, Phase 1/1b, Open-label, Multicenter Study of Bifunctional EGFR/TGFβ Fusion Protein BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-Driven Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-08-08DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)
-
CLINICAL_TRIALS study record update · 2025-08-07A Phase IIa (Pilot) Study of Neoadjuvant Chemotherapy With Folinic Acid, 5-FU, Irinotecan and Oxaliplatin (FOLFIRINOX) With Digoxin in Patients With Resectable Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2025-08-06Construction and Clinical Application of the Immune Map of Pancreatic Cancer Evolution
-
CLINICAL_TRIALS study record update · 2025-08-01Clinical Performance of Medical Device Software "Lipidica 1.0" for Processing Data Generated by Lipidomic Analysis in Pancreatic Cancer Screening
-
CLINICAL_TRIALS study record update · 2025-07-30HLA Typing and Tumor Neoantigen Identification for a Phase I/II Study of Autologous T-Cell Receptor-Engineered T Cells (TCR-T) Reactive Against Cancer-specific Mutations in Subjects With Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-07-28Exoluminate Study: Observational Registry Study to Assess Exo-PDAC Assay Performance for Detection of Pancreatic Adenocarcinoma (PDAC) in High-Risk or Clinically Suspicious Patients
-
CLINICAL_TRIALS study record update · 2025-07-23A Multicenter, 2-cohort Phase II GERCOR Study to Evaluate the Interest of Acupuncture on Oxaliplatin-induced Peripheral Neuropathy in Patients With Gastro-intestinal Solid Tumors Who Discontinued Oxaliplatin-based Chemotherapy (ACUPOX)
-
CLINICAL_TRIALS study record update · 2025-07-22Sintilimab Plus Chemotherapy and Radiotherapy for Patients With Inoperable Pancreatic Cancer: a Single-arm, Exploratory, Phase II Trial
-
CLINICAL_TRIALS study record update · 2025-07-20First-in-Human, Dose Finding, Open Label Phase 1A-1B Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies
-
CLINICAL_TRIALS study record update · 2025-07-18Phase II Trial of TAS-102 in Patients With Advanced, Refractory Pancreatic Adenocarcinoma
-
CLINICAL_TRIALS study record update · 2025-07-02An Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma: A Phase II Trial
-
CLINICAL_TRIALS study record update · 2025-07-02Phace I and II Study of Immunotherapy Strategy Used iNKT Cells and CD8+T Cells in Patients With Advanced Tumor
-
CLINICAL_TRIALS study record update · 2025-07-01Methylation Signature of Circulating Tumour DNA as a Prognostic and Theranostic Tool for Managing Pancreatic Ductal Adenocarcinoma
-
CLINICAL_TRIALS study record update · 2025-06-27Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] Dose Escalation Study for the Treatment of Advanced Solid Tumors: Phase 1 Clinical Trial
-
CLINICAL_TRIALS study record update · 2025-06-25Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study.
-
CLINICAL_TRIALS study record update · 2025-06-22Predictive Risk Factors for Postoperative Pancreatic Fistula After Pancreaticoduodenectomy for Malignancy.
-
CLINICAL_TRIALS study record update · 2025-06-18Evolution of Body Connection and Identity Post-surgery: The Pancreas Cancer Case
-
CLINICAL_TRIALS study record update · 2025-06-06A Phase 1b/2a, Double-blind, Placebo-controlled, Three Arm, Randomized Study Evaluating a Single Intravenous Push Followed by a Continuous Infusion of Certepetide Over 4 Hours When Added to Standard of Care (SoC) Versus Two Intravenous Pushes of Certepetide When Added to SoC, Versus SoC Alone in Subjects With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma (FORTIFIDE)
-
CLINICAL_TRIALS study record update · 2025-06-05Phase II, Neoadjuvant Study of Parasympathetic Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Borderline Resectable Pancreatic Adenocarcinoma